Biomaterials Market worth USD 297.08 Billion By 2027

The global Biomaterials Market is projected to reach USD 297.08 billion in 2027. The key factors influencing the market include the growing geriatric population, acceleration in chronic disorder incidence  such as cardiovascular disorders, orthopedic disorders, and an upsurge in the sports injuries, factors that are anticipated to impel the market growth in the forecast period. A higher traction of these materials are being observed in the usage of interacting with biological systems designed for medical treatments for correcting cardiovascular, orthopedic, dental, neurological disorders, among others.

Besides, the increasing technological developments. in the biomaterials industry, ascent in the adoption of implantable devices, heightening deprived to have better aesthetics boosting the demand for plastic surgeries using biomaterials are ascribed to propel the business in the coming years. For instance, the emerging 3D printing technology is being used for developing complex biomaterial structures. The requirement of resources and human resources for the manufacturing of such materials has been significantly reduced. Predicting the rampant investment in R&D in 3D printing innovation, the growth in the biomaterials market is significant.

Sample Report @

Further key findings from the report suggest

  • Increasing acceptance of metallic biomaterials in orthopedic applications due to their high load-bearing capacity is one factor driving the market growth. Besides, continuous advancements in the orthopedic implants technology by market vendors is also expected to propel the market share for the upcoming forecast period.
  • The plastic surgery industry is experiencing a dynamic transition and growing at a rapid rate in the biomaterials market during the forecast period. The rising geriatric population, positive public acceptance of cosmetic surgeries, and technological advances are factors increasing the demand for plastic surgeries.
  • In January 2019, ProMed Pharma and DSM Biomedical announced a business development partnership focused on polymeric drug delivery. Such other partnerships and strategic business expansion are increasing the demand for biomaterial market over the estimated period.
  • DSM Biomedical partnered with ProMed Pharma to control its biomedical biomaterials delivering novel controlled-release drug implants and corresponding combination devices with ProMed's micro molding and extrusion capabilities.

Key players in the market 

  • Advanced Biomaterials
  • Royal DSM
  • Carpenter Technology Corporation
  • BASF SE, Corbion
  • Cam Bioceramics B.V.
  • Celanese Corporation
  • CoorsTek Inc.
  • CeramTec
  • Evonik Industries

About Emergen Research 
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:
Eric Lee
Corporate Sales Specialist

Related Posts

Subscribe Our Newsletter